Cargando…

Macrovascular Complications in Patients with Diabetes and Prediabetes

Diabetes is a significant health problem worldwide, and its association with cardiovascular disease (CVD) was reported in several studies. Hyperglycemia and insulin resistance seen in diabetes and prediabetes lead to an increase in reactive oxygen species, which triggers intracellular molecular sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Dou, Refaat, Marwan, Mohammedi, Kamel, Jayyousi, Amin, Al Suwaidi, Jassim, Abi Khalil, Charbel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697393/ https://www.ncbi.nlm.nih.gov/pubmed/29238721 http://dx.doi.org/10.1155/2017/7839101

Ejemplares similares

Cardiac Complications of Diabetes
por: Abi Khalil, Charbel, et al.
Publicado: (2018)

Red Cell Distribution Width Is Associated with All-Cause and Cardiovascular Mortality in Patients with Diabetes
por: Al-Kindi, Sadeer G., et al.
Publicado: (2017)

Primary hyperaldosteronism is associated with increased mortality and morbidity in patients with hypertension and diabetes
por: Pillai, Krishnadev, et al.
Publicado: (2023)

Association of vitamin D(3) and its metabolites in patients with and without type 2 diabetes and their relationship to diabetes complications
por: Butler, Alexandra E., et al.
Publicado: (2020)

Association of vitamin D(2) and D(3) with type 2 diabetes complications
por: Ahmed, Lina H. M., et al.
Publicado: (2020)

Trends and Outcomes of Aortic Valve Replacement in Patients With Diabetes in the US
por: Khan, Sarah, et al.
Publicado: (2022)

Aspirin Use and Cardiovascular Outcome in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Population‐Based Cohort Study
por: Abi Khalil, Charbel, et al.
Publicado: (2018)

Temporal Trends in Outcomes of ST-Elevation Myocardial Infarction Patients With Heart Failure and Diabetes
por: Ali, Bassem, et al.
Publicado: (2022)

Angiogenic content of microparticles in patients with diabetes and coronary artery disease predicts networks of endothelial dysfunction
por: Marei, Isra, et al.
Publicado: (2022)

Diabetes outcomes in heart failure patients with hypertrophic cardiomyopathy
por: Mekhaimar, Menatalla, et al.
Publicado: (2022)

Type 2 diabetes and in-hospital sudden cardiac arrest in ST-elevation myocardial infarction in the US
por: Mhaimeed, Omar, et al.
Publicado: (2023)

Mortality and socio-economic outcomes among patients hospitalized for stroke and diabetes in the US: a recent analysis from the National Inpatient Sample
por: Tabbalat, Aya, et al.
Publicado: (2021)

Hypoglycemia is associated with a higher risk of mortality and arrhythmias in ST-elevation myocardial infarction, irrespective of diabetes
por: Humos, Basel, et al.
Publicado: (2022)

Machine Learning for Predicting Micro- and Macrovascular Complications in Individuals With Prediabetes or Diabetes: Retrospective Cohort Study
por: Schallmoser, Simon, et al.
Publicado: (2023)

Diabetes-related cardiovascular and economic burden in patients hospitalized for heart failure in the US: a recent temporal trend analysis from the National Inpatient Sample
por: Mekhaimar, Menatalla, et al.
Publicado: (2020)

Genetics of macrovascular complications in type 2 diabetes
por: Tonyan, Ziravard N, et al.
Publicado: (2021)

Protective role of NRF2 in macrovascular complications of diabetes
por: Wu, Junduo, et al.
Publicado: (2020)

Time to Development of Overt Diabetes and Macrovascular and Microvascular Complications Among Patients With Prediabetes: A Retrospective Cohort Study
por: Finocchio, Tyler, et al.
Publicado: (2021)

The Landscape of Glucose-Lowering Therapy and Cardiovascular Outcomes: From Barren Land to Metropolis
por: Nasrallah, Mona P., et al.
Publicado: (2017)

Beta-blockers and Short-Term Cardiovascular Outcomes In Patients Hospitalized For Acute Coronary Syndrome and a Left Ventricular Ejection Fraction ≥40%
por: Abi Khalil, Charbel, et al.
Publicado: (2020)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017)

Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chawla, Aastha, et al.
Publicado: (2016)

Diabetic microvascular complications: possible targets for improved macrovascular outcomes
por: D’Elia, John A, et al.
Publicado: (2010)

Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
por: Kim, Jung Hee, et al.
Publicado: (2011)

Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
por: Sun, Bao, et al.
Publicado: (2021)

Paraneoplastic hypoglycemia in a patient with a malignant solitary fibrous tumor
por: Mohammedi, Kamel, et al.
Publicado: (2014)

Type 2 Diabetes Mellitus and Macrovascular Complications
por: Shan, Peng-Fei, et al.
Publicado: (2017)

Role of Endoplasmic Reticulum Stress in Atherosclerosis and Diabetic Macrovascular Complications
por: Chistiakov, Dmitry A., et al.
Publicado: (2014)

Altered Circulating microRNAs in Patients with Diabetic Neuropathy and Corneal Nerve Loss: A Pilot Study
por: Khan, Adnan, et al.
Publicado: (2022)

Macrovascular complication phenotypes in type 2 diabetic patients
por: Papa, Giuseppe, et al.
Publicado: (2013)

The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates
por: Al-Maskari, Fatma, et al.
Publicado: (2007)

Circulating microparticles in acute diabetic Charcot foot exhibit a high content of inflammatory cytokines, and support monocyte-to-osteoclast cell induction
por: Pasquier, Jennifer, et al.
Publicado: (2017)

Cost of diabetes mellitus and related macrovascular complications in Turkiye
por: Birinci, Suayip, et al.
Publicado: (2023)

Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways
por: Zakir, Mehreen, et al.
Publicado: (2023)

Endothelial dysfunction in diabetes mellitus
por: Hadi, Hadi AR, et al.
Publicado: (2007)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
por: Tang, L., et al.
Publicado: (2017)

Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chauhan, Anubhav, et al.
Publicado: (2016)

Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies
por: Rangel, Érika B., et al.
Publicado: (2019)

Aortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 Diabetes
por: Cardoso, Claudia R. L., et al.
Publicado: (2016)

Animal Models of Diabetic Macrovascular Complications: Key Players in the Development of New Therapeutic Approaches
por: Heinonen, Suvi E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3ph6gv69lrottv9nq5ecf0if5n